Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.63 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | SYK | P43405 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.49 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | BCR | P11274 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29239355 | 0.98 | PDPK1 (0.61) | PDPK1LOXL2ADRB2ESR1ESR2 | |
| SCHEMBL2295510 | 0.89 | PDPK1 (0.52) | PDPK1LOXL2ADRB2ESR1ESR2 | |
| SCHEMBL722198 | 0.89 | PDPK1 (0.77) | PDPK1LOXL2ADRB2CYP2A6SMPD3 | |
| SCHEMBL23328027 | 0.81 | ESR1 (0.50) | PDPK1LOXL2ADRB2ESR1ESR2 | |
| Ethoxycarbonyl Group SCHEMBL29291640 | 0.81 | ADRB2 (0.47) | PDPK1LOXL2ADRB2ESR1ESR2 | |
| SCHEMBL17704291 | 0.80 | PDPK1 (0.65) | PDPK1LOXL2ADRB2CYP2A6SMPD3 | |
| SCHEMBL533419 | 0.79 | LOXL2 (0.67) | PDPK1LOXL2ADRB2CYP2A6SMPD3 | |
| SCHEMBL10576999 | 0.78 | PDPK1 (0.63) | PDPK1LOXL2ADRB2CYP2A6SMPD3 | |
| SCHEMBL16119908 | 0.78 | PDPK1 (0.63) | PDPK1LOXL2ADRB2CYP2A6SMPD3 | |
| SCHEMBL21791658 | 0.78 | LOXL2 (0.71) | PDPK1LOXL2ADRB2CYP2A6SMPD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270199-A1 | THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME | ARKANSAS STATE UNIV JONESBORO (US) | 2025-08-28 | — | — | US | claimed |
| EP-3494396-B1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY INC (US) | 2025-06-11 | — | — | EP | claimed |
| CN-115724641-B | Mildew-proof antibacterial autoclaved aerated block and preparation method thereof | 广州市贤达建材有限公司 | 2024-02-23 | — | — | CN | claimed |
| WO-2023192595-A1 | THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME | Arkansas State University - Jonesboro (US) | 2023-10-05 | — | — | WO | claimed |
| CN-116836127-A | Hybrid bismuth-chloride material and reversible photochromic application | 济南大学 | 2023-10-03 | — | — | CN | claimed |
| CN-115724641-A | Mildew-proof antibacterial autoclaved aerated building block and preparation method thereof | 广州市贤达建材有限公司 | 2023-03-03 | — | — | CN | claimed |
| EP-0938677-A4 | CHEMILUMINESCENT DETECTION METHODS USING DUAL ENZYME-LABELED BINDING PARTNERS | LUMIGEN INC (US) | 2000-09-27 | — | — | EP | claimed |
| EP-0938677-A1 | CHEMILUMINESCENT DETECTION METHODS USING DUAL ENZYME-LABELED BINDING PARTNERS | LUMIGEN, INC. (US) | 1999-09-01 | — | — | EP | claimed |
| US-5843666-A | Chemiluminescent detection methods using dual enzyer-labeled binding partners | LUMIGEN, INC. (US) | 1998-12-01 | — | — | US | claimed |
| WO-1998021586-A1 | CHEMILUMINESCENT DETECTION METHODS USING DUAL ENZYME-LABELED BINDING PARTNERS | LUMIGEN, INC. (US) | 1998-05-22 | — | — | WO | claimed |
| JP-6329647-A | — | — | None | — | — | JP | disclosed |
| CN-116836127-B | Hybrid bismuth-chloride material and reversible photochromic application | 济南大学 | 2025-09-26 | — | — | CN | disclosed |
| US-20250270199-A1 | THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME | ARKANSAS STATE UNIV JONESBORO (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250270199-A1 | THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME | ARKANSAS STATE UNIV JONESBORO (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250216782-A1 | MASKING PROCESS USING SWITCHABLE POLYMER | TOKYO ELECTRON LTD (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-0556123-A1 | Pyrethrinoid esters of thiazolylalcohols, process for their preparation and their use as pesticides | ROUSSEL UCLAF (FR) | 1993-08-18 | — | — | EP | disclosed |
| EP-0343307-A1 | 4-Piperidinealkanamine derivatives | FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (ES) | 1989-11-29 | — | — | EP | disclosed |
| EP-0039892-B1 | SUBSTITUTED PHENYL ETHERS | CIBA-GEIGY AG (CH) | 1986-12-30 | — | — | EP | disclosed |
| US-4559354-A | ADRENERGIC BLOCKING AGENTS AND STIMULANTS; CARDIOTONIC, ANTIARRHYTHMIA AND INOTROPIC AGENTS | CIBA-GEIGY CORPORATION (US) | 1985-12-17 | — | — | US | disclosed |
| EP-0039892-A1 | Substituted phenyl ethers | CIBA-GEIGY AG (CH) | 1981-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270199-A1 | THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME | TST, GOT2, TPMT | PDPK1 3270/4885LOXL2 722/4885ADRB2 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.